Akums Drugs and Pharmaceuticals informs about transcript of earnings call

Akums Drugs & Pharmaceuticals Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 544222 | NSE: AKUMS

19 Feb 2026 Evaluate

Pursuant to the Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) 2015, Akums Drugs and Pharmaceuticals has informed that it enclosed the transcript of earnings/analyst conference call held on Monday, February 16, 2026 at 12:00 PM (IST) on Un-audited financial results for Q3 of FY26. The said transcript be also available on the Company’s website https://www.akums.in/investors/investors-meet/.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1842.00
Dr. Reddys Labs.	1161.00
Cipla	1365.00
Lupin	2096.00
Zydus Lifesciences	1119.50
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.